Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.47 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6672713 | 0.91 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL15180056 | 0.87 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL5090250 | 0.87 | CA2 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL15180064 | 0.87 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL9587049 | 0.82 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL4879495 | 0.82 | CA1 (0.45) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL4437362 | 0.82 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL1512024 | 0.82 | CA1 (0.55) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL15180049 | 0.82 | CA1 (0.50) | CA1CA2ALDH1A1PTGS2TNFRSF1A | |
| SCHEMBL30925599 | 0.82 | CA1 (0.46) | CA1CA2ALDH1A1PTGS2TNFRSF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11077433-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-20200261898-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI, INC. (US) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200261898-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | SREBF1, F2, SREBF2 | CA1 3693/4885CA2 4484/4885ALDH1A1 1913/4885 |
| US-11077433-B2 | Production of fatty olefin derivatives via olefin metathesis | SREBF1, F2, SREBF2 | CA1 3693/4885CA2 4484/4885ALDH1A1 1913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.